Adult Acute Myeloblastic Leukemia Without Maturation (M1) Completed Phase 3 Trials for Daunorubicin (DB00694)

IndicationStatusPhase
DBCOND0028523 (Adult Acute Myeloblastic Leukemia Without Maturation (M1))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003190Combination Chemotherapy With or Without Valspodar in Treating Patients With Previously Untreated Acute Myeloid LeukemiaTreatment
NCT00006363Combination Chemotherapy With or Without PSC 833, Peripheral Stem Cell Transplantation, and/or Interleukin-2 in Treating Patients With Acute Myeloid LeukemiaTreatment